Picture of Adherium logo

ADR — Adherium News Story

0.000.00%
au flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Australia's Adherium climbs to 1-1/2-year high after US FDA approval

** Shares of Adherium  ADR.AX  rise as much as 132.5% to
A$0.093, set for their best day, if gains hold
    ** The medical tech co says nasal device Hailie Smartinhaler
has received clearance from the U.S. Food and Drug
Administration for use with AstraZeneca's Airsupra and Breztri
inhalation devices
    ** Stock at its highest level since Sept 23, 2022
    ** About 7.6 mln shares change hands, compared with the
30-day average volume of 64,438     
    ** ADR stock down 28.6% YTD, as of last close
    

 (Reporting by Adwitiya Srivastava in Bengaluru)
 ((Adwitiya.Srivastava@thomsonreuters.com;))

Recent news on Adherium

See all news